Charcot-Marie-Tooth Disease, Type IABALTiCNCT02982343
BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease
A study testing Falls management plus exercise training and Falls management only in people with Charcot-Marie-Tooth Disease, Type IA, run by University College London Hospitals at 1 site in United Kingdom.
Trial summary
Charcot Marie Tooth (CMT) is the most common inherited neuropathy. It affects the nerves of the hands and feet first, slowly progressing towards the centre of the body. It causes varying degrees of weakness and reduced feeling, usually affecting the feet and ankles first. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Charcot-Marie-Tooth Disease, Type IA
- What is being tested?
- Falls management plus exercise training and Falls management only
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 16 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Dec 2016to Mar 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Genetically confirmed diagnosis of CMT1a
- History of falls
- Mixed sensory and motor presentation
- Over 18 years
- Able to stand unsupported for five minutes
- Able to walk for 50m with or without a walking stick or orthotic devices
Who cannot join
- Presence of other significant neurological disorders (such as multiple sclerosis, cerebrovascular diseases, epilepsy, movement disorders), or major comorbidities (e.g. vestibular dysfunction, use of medication which may affect balance, cognitive impairment, presence of medical conditions in which exercise training may be detrimental).
- Presence of peripheral neuropathy caused by a condition other then CMT.
- Limb surgery during the six months prior to screening (or planned before final assessment).
- Participation in any other concurrent intervention trial, or less than six months after cessation of an intervention trial.
- Women of child-bearing age if they are pregnant, planning a pregnancy during their time in the study or in the 12 weeks following giving birth. This is due to the effects of pregnancy on balance.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
National Hospital for Neurology and Neurosurgery, UCLH
London, WC1N 3BG
About this study
Charcot Marie Tooth (CMT) is the most common inherited neuropathy. It affects the nerves of the hands and feet first, slowly progressing towards the centre of the body. It causes varying degrees of weakness and reduced feeling, usually affecting the feet and ankles first. High incidence of falls and knock on effects in quality of life are common. This is a lifelong condition which, though not life limiting, does not have a cure. Research into the effect of balance rehabilitation in people with CMT has been limited to traditional exercises, which do not address the complex nature of balance impairments in this condition. Multi-sensory rehabilitation has proved beneficial in improving balance in people with sensory neuropathy. Research shows that strengthening trunk muscles can improve balance in older people. Trunk and muscles close to it are largely unaffected in people with CMT, therefore these muscles could be strengthened in these patients. This study proposes to assess the feasibility of multi-sensory balance training, strength training with a focus on the trunk and muscles close to the trunk, and falls management education. This comprehensive approach is reflective of a clinical physiotherapy programme. Though a life-long condition, many people with CMT lead full lives. A home based programme is proposed to so that patients can fit it into their lives without having to travel for treatment. Therapists will use self-management principles within treatment. Measurements will be taken prior to and following treatment including physical measures, questionnaires and interviews. The physiotherapy interventions will be taught home and data collection will be at the National Hospital for Neurology and Neurosurgery, University College London Hospitals (UCLH).
Read the detailed description
A recent, unpublished focus group study of people with CMT found that they reported more falls than healthy people. They reported problems walking on uneven surfaces, difficulty getting off the floor and a necessity to consciously think about every step to avoid falling while walking (GM Ramdharry et al., 2015). A retrospective survey of people with CMT found that 89% of the 94 respondents reported falls to the ground. Half of them reported falling at least once a month with 5% falling every day (Ramdharry et al., 2011). We have just completed an exploratory study of factors predicting falls risk. Preliminary analysis of prospective falls data for 32 people over 6 months showed that they fell a median of 4 times (range 0 - 54 falls) and functional balance performance may be predictive (Ramdharry et al., 2015). A study of people with CMT1a found that sensory impairment increased visual dependence for a static balance task (van der Linden et al., 2010). There has only been one small study of balance training in people with CMT, comparing a novel rehabilitation device with more traditional exercises (Matjacić and Zupan, 2006). Both interventions showed improvement in functional balance scores. Studies of proximal strength training in CMT have shown improvements in walking parameters (Chetlin et al., 2004; Lindeman et al., 1995), but the effect on balance has not been explored. Because of the mixed sensori-motor presentation of people with CMT, a combined approach of multi-sensory balance training and proximal strengthening will be delivered. A home-based model has been proposed as CMT is a life-long condition that needs to be managed by the individual outside of the medical or therapy environment.
STUDY DESIGN \& JUSTIFICATION A single blinded randomised controlled design has been chosen in this feasibility study. The intention is to see if there is an effect of the intervention to later be explored in a larger randomized controlled trial. A blinded assessor will measure balance performance prior to randomisation and following the 12 weeks of either intervention or control. They will also undertake qualitative interviews prior to randomization and following final measurement session. Interviews will inform the intervention and its acceptability. All participants will receive a falls assessment and falls education. Following randomisation, participants will either receive the 12-week intervention or control period. The intervention will include a holistic programme of physiotherapy including strength training of muscle groups unaffected by the condition and multi-sensory exercises to target balance. The program will be delivered by a physiotherapist trained in delivering treatment under the principles of self-management. Exercises will be carried out by the patients in their own homes and monitored by the research physiotherapist, progressing as appropriate. Those randomized to the control arm will receive monitoring telephone calls throughout this 12-week period.
RECRUITMENT Patients will be recruited from outpatient neurology clinics at Queen Square which specialise in the diagnosis and management of CMT. Patients who fit the inclusion criteria will be approached and the trial will be described to them. Written information will be provided and arrangement made for a way to make contact once they have decided about whether they wish to proceed with screening. All patients who agree to proceed will go through a screening which will take place over the telephone. Those who pass screening will be provided with falls diary postcards or arrangement for falls diary emails, which they will be asked to monitor and report for one month. A sample will be invited for a qualitative interview. Arrangement will be made for them to attend a baseline measurement session, falls assessment, and falls education following the month-long falls monitoring.
Measures will include:
Patient reported questionnaires of balance confidence, mood, walking ability and physical functioning 10m walk test / 6 minute walk test Berg Balance Scale Bruininks Oseretsky Test (BOT) BESTest Functional balance tests using force plate and movement analysis equipment Strength testing of the lower limbs and hands Charcot Marie Tooth Examination Score (CMTES) A block randomisation will occur following the baseline measurement and falls education session with allocation either being to a control arm or an intervention arm. This will be done by the PI or research physiotherapist who will remain un-blinded. Contact with the blinded assessor will cease until the final measurement session 12 weeks later.
INTERVENTION:
If randomised to the control arm of the study, participants will be advised that the research physiotherapist will contact them monthly to monitor any falls or issues. For those randomised to the intervention arm, a home visit will be arranged with the research physiotherapist as soon as possible. During this session, the research physiotherapist will provide the participant with exercises to strengthen the muscles of the trunk and proximal muscles using body weight and graded ankle weights. Strength training will be performed 4 times per week. They will also give a selection of exercises targeting balance to challenge stability and sensory feedback. Participants will be asked to perform balance exercises daily. A risk assessment will be undertaken with guidance on how to ensure safety when doing the exercises. An exercise diary will be provided for the participants to monitor exercise frequency.
Arrangements will be made for weekly telephone calls with the research physiotherapist to monitor progress and a provisional date set for the first monthly home monitoring visit. Participants in the intervention arm will be contacted weekly for 12 weeks on the study. The research physiotherapist will visit them at home to monitor and progress exercises once a month during this time.
QUALITATIVE RESEARCH At the consent meeting all patients will be invited to take part in interviews conducted after the consent meeting and following completion of the final measurements. They will be made aware that participation in the interviews is supplementary to the main study and they are free to decline. Purposive sampling will be used to ensure a sample of maximum diversity of age, gender, and symptom severity. Potential qualitative interview participants will be given written details of the qualitative study and asked to give their consent to be interviewed if they are willing to take part. The interview will be audio recorded and consist of a dialogue between the interviewer (the researcher) and the participant. A topic guide will be used during the interviews, but the participant will be invited to raise issues of importance to them. Data analysis will be iterative, in that it will be continually analysed throughout the data collection process and used to inform following interviews.
PROCEDURES TO DEAL WITH RESEARCHER EFFECTS AND BIAS Assessments will be carried out by a blinded assessor to standardise treatment during tests. Falls assessment and falls education will be provided at the baseline measurement session by the blinded assessor, prior to participant randomisation. In this way participants will be given the same treatment. The blinded assessor will perform final measurements. The participant will be reminded prior to the start the final session to not mention what they may or may not have been doing in the 12 weeks prior to maintain blinding throughout the session
- Conditions
- Charcot-Marie-Tooth Disease, Type IA
- Being tested
- Falls management plus exercise training, Falls management only
- Medical subject headings
- Charcot-Marie-Tooth Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Falls management plus exercise trainingBehavioural
Participants will undergo a session of falls management and education followed by 12 weeks of strength and balance training. Strength training will be performed 4 times per week. Resistance training of the proximal muscles will be prescribed progressing to loads of 60% of 1 repetition maximum, 8-12 repetitions. Weaker muscles will be trained using 2 sets of 8-12 repetitions against gravity. They will also give a selection of exercises targeting balance to challenge stability and sensory feedback using equipment such as foam cushions, though will be individual based on participants' limitations and abilities. Participants will be asked to perform balance exercises daily.
Falls management onlyBehavioural
Participants will undergo a session of falls management and education.
| Study group | Role | What they receive |
|---|---|---|
| Falls management plus exercise training | Experimental | Falls management and education session. Home proximal lower limb strength training and multi-sensory balance training. Receives: Behavioral: Falls management plus exercise training |
| Falls management only | Active comparator | Falls management and education session only. Receives: Behavioral: Falls management only |
What is being measured
The primary outcome is the main question the study is designed to answer.
Balance performance
Balance performance will be measured using laboratory measures of postural stability during static and dynamic tasks. Centre of pressure excursion and velocity will be the main variables
Measured: 12 weeks
Secondary outcomes (13)
Recruitment rate
For this feasibility study, recruitment rate data will be gathered
Measured: 1 year
Falls monitoring
Falls monitoring will be done one month before, during the 12 week invention/control period and one month afterwards using postcards or a web based app, depending on participant preference.
Measured: 20 weeks
Bruininks Oseretsky Test (BOT)
Clinician rated measure of functional balance performance.
Measured: 12 weeks
Berg Balance test
Clinician rated measure of functional balance performance.
Measured: 12 weeks
BESTest
Clinician rated measure of functional balance performance.
Measured: 12 weeks
10 minute timed walk
Walking speed test
Measured: 12 weeks
Quantitative lower limb muscle strength testing
Hand-held myometry protocol performed by rater for the major lower limb muscle groups.
Measured: 12 weeks
CMTES: Charcot Marie Tooth Examination Score
Clinician rated disease severity scale
Measured: 12 weeks
Falls Self Efficacy Scale
Patient reported outcome measure of balance confidence. Questionnaire.
Measured: 12 weeks
Walk-12
Patient reported outcome measure of walking function. Questionnaire.
Measured: 12 weeks
IPAQ: International Physical Activity Questionnaire
Patient reported outcome measure of physical activity. Questionnaire.
Measured: 12 weeks
SF36: Short Form 36
Patient reported outcome measure of health related quality of life. Questionnaire.
Measured: 12 weeks
Hospital Anxiety and Depression Score
Patient reported outcome measure of depression and anxiety symptoms. Questionnaire.
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2016 (estimated)
- Study startDec 2016
- Primary completionMar 2017
- Study completionMar 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Charcot-Marie-Tooth Disease, Type IAStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 16 participants (actual)
Sponsor and investigators
- Lead sponsor
- University College London Hospitals
- Sponsor type
- University, hospital or other
- Collaborators
- Charcot Marie Tooth United Kingdom, Kingston University
- Responsible party
- Principal investigator, Gita Ramdharry, University College London Hospitals
- Investigators
- Gita M Ramdharry, PhD, Principal investigator, University College London Hosptials NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02982343
- Sponsor's protocol ID
- 16/LO/0720
- Acronym
- BALTiC
- Status last verified
- May 2018
- First submitted
- 28 Nov 2016
- Last updated
- 3 May 2018
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Ramdharry, G., M. Dudziec, D. Tropman, E. Dewar, A. Wallace, M. Laura, R. Grant, and M. Reilly. 2015. 'Exploring the Causes of Falls and Balance Impairments in People with Charcot-Marie Tooth Disease'. Physiotherapy 101 (May): e1255. doi:10.1016/j.physio.2015.03.1159.
Ramdharry GM, Pollard A, Anderson C, Laura M, Murphy SM, Dudziec M, Dewar EL, Hutton E, Grant R, Reilly MM. A pilot study of proximal strength training in Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2014 Dec;19(4):328-32. doi: 10.1111/jns.12100.
PubMed 25582960van der Linden MH, van der Linden SC, Hendricks HT, van Engelen BG, Geurts AC. Postural instability in Charcot-Marie-Tooth type 1A patients is strongly associated with reduced somatosensation. Gait Posture. 2010 Apr;31(4):483-8. doi: 10.1016/j.gaitpost.2010.02.005. Epub 2010 Mar 11.
PubMed 20226674Matjacic Z, Zupan A. Effects of dynamic balance training during standing and stepping in patients with hereditary sensory motor neuropathy. Disabil Rehabil. 2006 Dec 15;28(23):1455-9. doi: 10.1080/09638280600646169.
PubMed 17166808Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil. 2004 Aug;85(8):1217-23. doi: 10.1016/j.apmr.2003.12.025.
PubMed 15295743Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, Koke A. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995 Jul;76(7):612-20. doi: 10.1016/s0003-9993(95)80629-6.
PubMed 7605179
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease
- ClinicalTrials.gov ID
- NCT02982343
- Acronym / sponsor ID
- BALTiC / 16/LO/0720
- Conditions
- Charcot-Marie-Tooth Disease, Type IA
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 16 participants (actual)
- Lead sponsor
- University College London HospitalsUniversity, hospital or other
- Collaborators
- Charcot Marie Tooth United Kingdom, Kingston University
- Study start
- Dec 2016 (actual)
- Primary completion
- Mar 2017 (actual)
- Study completion
- Mar 2018 (actual)
- First posted
- 5 Dec 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Charcot Marie Tooth (CMT) is the most common inherited neuropathy. It affects the nerves of the hands and feet first, slowly progressing towards the centre of the body. It causes varying degrees of weakness and reduced feeling, usually affecting the feet and ankles first. High incidence of falls and knock on effects in quality of life are common. This is a lifelong condition which, though not life limiting, does not have a cure. Research into the effect of balance rehabilitation in people with CMT has been limited to traditional exercises, which do not address the complex nature of balance impairments in this condition. Multi-sensory rehabilitation has proved beneficial in improving balance in people with sensory neuropathy. Research shows that strengthening trunk muscles can improve balance in older people. Trunk and muscles close to it are largely unaffected in people with CMT, therefore these muscles could be strengthened in these patients. This study proposes to assess the feasibility of multi-sensory balance training, strength training with a focus on the trunk and muscles close to the trunk, and falls management education. This comprehensive approach is reflective of a clinical physiotherapy programme. Though a life-long condition, many people with CMT lead full lives. A home based programme is proposed to so that patients can fit it into their lives without having to travel for treatment. Therapists will use self-management principles within treatment. Measurements will be taken prior to and following treatment including physical measures, questionnaires and interviews. The physiotherapy interventions will be taught home and data collection will be at the National Hospital for Neurology and Neurosurgery, University College London Hospitals (UCLH).
Detailed description
A recent, unpublished focus group study of people with CMT found that they reported more falls than healthy people. They reported problems walking on uneven surfaces, difficulty getting off the floor and a necessity to consciously think about every step to avoid falling while walking (GM Ramdharry et al., 2015). A retrospective survey of people with CMT found that 89% of the 94 respondents reported falls to the ground. Half of them reported falling at least once a month with 5% falling every day (Ramdharry et al., 2011). We have just completed an exploratory study of factors predicting falls risk. Preliminary analysis of prospective falls data for 32 people over 6 months showed that they fell a median of 4 times (range 0 - 54 falls) and functional balance performance may be predictive (Ramdharry et al., 2015). A study of people with CMT1a found that sensory impairment increased visual dependence for a static balance task (van der Linden et al., 2010). There has only been one small study of balance training in people with CMT, comparing a novel rehabilitation device with more traditional exercises (Matjacić and Zupan, 2006). Both interventions showed improvement in functional balance scores. Studies of proximal strength training in CMT have shown improvements in walking parameters (Chetlin et al., 2004; Lindeman et al., 1995), but the effect on balance has not been explored. Because of the mixed sensori-motor presentation of people with CMT, a combined approach of multi-sensory balance training and proximal strengthening will be delivered. A home-based model has been proposed as CMT is a life-long condition that needs to be managed by the individual outside of the medical or therapy environment.
STUDY DESIGN \& JUSTIFICATION A single blinded randomised controlled design has been chosen in this feasibility study. The intention is to see if there is an effect of the intervention to later be explored in a larger randomized controlled trial. A blinded assessor will measure balance performance prior to randomisation and following the 12 weeks of either intervention or control. They will also undertake qualitative interviews prior to randomization and following final measurement session. Interviews will inform the intervention and its acceptability. All participants will receive a falls assessment and falls education. Following randomisation, participants will either receive the 12-week intervention or control period. The intervention will include a holistic programme of physiotherapy including strength training of muscle groups unaffected by the condition and multi-sensory exercises to target balance. The program will be delivered by a physiotherapist trained in delivering treatment under the principles of self-management. Exercises will be carried out by the patients in their own homes and monitored by the research physiotherapist, progressing as appropriate. Those randomized to the control arm will receive monitoring telephone calls throughout this 12-week period.
RECRUITMENT Patients will be recruited from outpatient neurology clinics at Queen Square which specialise in the diagnosis and management of CMT. Patients who fit the inclusion criteria will be approached and the trial will be described to them. Written information will be provided and arrangement made for a way to make contact once they have decided about whether they wish to proceed with screening. All patients who agree to proceed will go through a screening which will take place over the telephone. Those who pass screening will be provided with falls diary postcards or arrangement for falls diary emails, which they will be asked to monitor and report for one month. A sample will be invited for a qualitative interview. Arrangement will be made for them to attend a baseline measurement session, falls assessment, and falls education following the month-long falls monitoring.
Measures will include:
Patient reported questionnaires of balance confidence, mood, walking ability and physical functioning 10m walk test / 6 minute walk test Berg Balance Scale Bruininks Oseretsky Test (BOT) BESTest Functional balance tests using force plate and movement analysis equipment Strength testing of the lower limbs and hands Charcot Marie Tooth Examination Score (CMTES) A block randomisation will occur following the baseline measurement and falls education session with allocation either being to a control arm or an intervention arm. This will be done by the PI or research physiotherapist who will remain un-blinded. Contact with the blinded assessor will cease until the final measurement session 12 weeks later.
INTERVENTION:
If randomised to the control arm of the study, participants will be advised that the research physiotherapist will contact them monthly to monitor any falls or issues. For those randomised to the intervention arm, a home visit will be arranged with the research physiotherapist as soon as possible. During this session, the research physiotherapist will provide the participant with exercises to strengthen the muscles of the trunk and proximal muscles using body weight and graded ankle weights. Strength training will be performed 4 times per week. They will also give a selection of exercises targeting balance to challenge stability and sensory feedback. Participants will be asked to perform balance exercises daily. A risk assessment will be undertaken with guidance on how to ensure safety when doing the exercises. An exercise diary will be provided for the participants to monitor exercise frequency.
Arrangements will be made for weekly telephone calls with the research physiotherapist to monitor progress and a provisional date set for the first monthly home monitoring visit. Participants in the intervention arm will be contacted weekly for 12 weeks on the study. The research physiotherapist will visit them at home to monitor and progress exercises once a month during this time.
QUALITATIVE RESEARCH At the consent meeting all patients will be invited to take part in interviews conducted after the consent meeting and following completion of the final measurements. They will be made aware that participation in the interviews is supplementary to the main study and they are free to decline. Purposive sampling will be used to ensure a sample of maximum diversity of age, gender, and symptom severity. Potential qualitative interview participants will be given written details of the qualitative study and asked to give their consent to be interviewed if they are willing to take part. The interview will be audio recorded and consist of a dialogue between the interviewer (the researcher) and the participant. A topic guide will be used during the interviews, but the participant will be invited to raise issues of importance to them. Data analysis will be iterative, in that it will be continually analysed throughout the data collection process and used to inform following interviews.
PROCEDURES TO DEAL WITH RESEARCHER EFFECTS AND BIAS Assessments will be carried out by a blinded assessor to standardise treatment during tests. Falls assessment and falls education will be provided at the baseline measurement session by the blinded assessor, prior to participant randomisation. In this way participants will be given the same treatment. The blinded assessor will perform final measurements. The participant will be reminded prior to the start the final session to not mention what they may or may not have been doing in the 12 weeks prior to maintain blinding throughout the session
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Falls management plus exercise training | Experimental | Behavioral: Falls management plus exercise trainingFalls management and education session. Home proximal lower limb strength training and multi-sensory balance training. |
| Falls management only | Active comparator | Behavioral: Falls management onlyFalls management and education session only. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Genetically confirmed diagnosis of CMT1a
- History of falls
- Mixed sensory and motor presentation
- Over 18 years
- Able to stand unsupported for five minutes
Key exclusion criteria (5 listed)
- Presence of other significant neurological disorders (such as multiple sclerosis, cerebrovascular diseases, epilepsy, movement disorders), or major comorbidities (e.g. vestibular dysfunction, use of medication which may affect balance, cognitive impairment, presence of medical conditions in which exercise training may be detrimental).
- Presence of peripheral neuropathy caused by a condition other then CMT.
- Limb surgery during the six months prior to screening (or planned before final assessment).
- Participation in any other concurrent intervention trial, or less than six months after cessation of an intervention trial.
- Women of child-bearing age if they are pregnant, planning a pregnancy during their time in the study or in the 12 weeks following giving birth. This is due to the effects of pregnancy on balance.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Falls management plus exercise trainingParticipants will undergo a session of falls management and education followed by 12 weeks of strength and balance training. Strength training will be performed 4 times per week. Resistance training of the proximal muscles will be prescribed progressing to loads of 60% of 1 repetition maximum, 8-12 repetitions. Weaker muscles will be trained using 2 sets of 8-12 repetitions against gravity. They will also give a selection of exercises targeting balance to challenge stability and sensory feedback using equipment such as foam cushions, though will be individual based on participants' limitations and abilities. Participants will be asked to perform balance exercises daily. | Behavioural | Falls management plus exercise training |
| Falls management onlyParticipants will undergo a session of falls management and education. | Behavioural | Falls management only |
Primary outcome
Balance performance
Time frame: 12 weeks
Balance performance will be measured using laboratory measures of postural stability during static and dynamic tasks. Centre of pressure excursion and velocity will be the main variables
13 secondary outcomes
Recruitment rate
Time frame: 1 year
Falls monitoring
Time frame: 20 weeks
Bruininks Oseretsky Test (BOT)
Time frame: 12 weeks
Berg Balance test
Time frame: 12 weeks
BESTest
Time frame: 12 weeks
10 minute timed walk
Time frame: 12 weeks
Quantitative lower limb muscle strength testing
Time frame: 12 weeks
CMTES: Charcot Marie Tooth Examination Score
Time frame: 12 weeks
Falls Self Efficacy Scale
Time frame: 12 weeks
Walk-12
Time frame: 12 weeks
IPAQ: International Physical Activity Questionnaire
Time frame: 12 weeks
SF36: Short Form 36
Time frame: 12 weeks
Hospital Anxiety and Depression Score
Time frame: 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2018.
- BackgroundRamdharry, G., M. Dudziec, D. Tropman, E. Dewar, A. Wallace, M. Laura, R. Grant, and M. Reilly. 2015. 'Exploring the Causes of Falls and Balance Impairments in People with Charcot-Marie Tooth Disease'. Physiotherapy 101 (May): e1255. doi:10.1016/j.physio.2015.03.1159.
- Background: PubMed 25582960Ramdharry GM, Pollard A, Anderson C, Laura M, Murphy SM, Dudziec M, Dewar EL, Hutton E, Grant R, Reilly MM. A pilot study of proximal strength training in Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2014 Dec;19(4):328-32. doi: 10.1111/jns.12100.
- Background: PubMed 20226674van der Linden MH, van der Linden SC, Hendricks HT, van Engelen BG, Geurts AC. Postural instability in Charcot-Marie-Tooth type 1A patients is strongly associated with reduced somatosensation. Gait Posture. 2010 Apr;31(4):483-8. doi: 10.1016/j.gaitpost.2010.02.005. Epub 2010 Mar 11.
- Background: PubMed 17166808Matjacic Z, Zupan A. Effects of dynamic balance training during standing and stepping in patients with hereditary sensory motor neuropathy. Disabil Rehabil. 2006 Dec 15;28(23):1455-9. doi: 10.1080/09638280600646169.
- Background: PubMed 15295743Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil. 2004 Aug;85(8):1217-23. doi: 10.1016/j.apmr.2003.12.025.
- Background: PubMed 7605179Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, Koke A. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995 Jul;76(7):612-20. doi: 10.1016/s0003-9993(95)80629-6.
- Individual participant dataSharing planned: No
Related trials for Charcot-Marie-Tooth Disease, Type IA
RecruitingObservational study
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
Charcot-Marie-Tooth, CMT1A
Active, not recruiting
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Charcot-Marie-Tooth Disease Type 1A
Active, not recruiting
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
Charcot-Marie-Tooth Disease Type 1A
RecruitingObservational study
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Not yet recruitingObservational study
Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
Foot Drop, Charcot-Marie-Tooth Disease Type 1A
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gita M Ramdharry, PhD principal investigator
University College London Hosptials NHS Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Falls management plus exercise training and Falls management only in people with Charcot-Marie-Tooth Disease, Type IA, run by University College London Hospitals at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Balance performance (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02982343, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2018.